Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arianna Rodríguez-Coello

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Vaccines|June 27, 2025
Engineering and Evaluation of a Live-Attenuated Vaccine Candidate with Enhanced Type 1 Fimbriae Expression to Optimize Protection Against <i>Salmonella</i> TyphimuriumPatricia García, Arianna Rodríguez-Coello, Andrea García-Pose, et al.
Journal of Physiology and Biochemistry|June 19, 2023
Study of hydrogen sulfide biosynthesis in synovial tissue from diabetes-associated osteoarthritis and its influence on macrophage phenotype and abundanceNatalia Lendoiro-Cino, Arianna Rodríguez-Coello, Anna Saborido, et al.
International Journal of Biological Macromolecules|September 18, 2023
Anti-inflammatory potential of ulvanNoelia Flórez-Fernández, Arianna Rodríguez-Coello, Thomas Latire, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2025
The novel polymyxin analogue SPR206 exhibits higher activity than colistin against both colistin-susceptible and colistin-resistant strains of <i>Acinetobacter baumannii</i>Michelle Outeda-García, Andrea Garcia-Pose, Paula Guijarro-Sánchez, et al.
New Microbes and New Infections|February 6, 2026
<i>Enterococcus thailandicus</i>: Genomic evidence of a potential new player in enterococcal virulence and antimicrobial resistanceJuan C Vázquez-Ucha, Ana C Almeida-Santos, David Velasco, et al.
Antimicrobial Agents and Chemotherapy|December 22, 2025
Antibacterial activity of enmetazobactam against <i>Acinetobacter</i> spp.: a molecular dissection of mechanism of action and resistance determinantsGabriela-Alejandra Báez-Barroso, Arianna Rodríguez-Coello, Juan Carlos Vázquez-Ucha, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 3, 2024
Activity and resistance mechanisms of the third generation tetracyclines tigecycline, eravacycline and omadacycline against nationwide Spanish collections of carbapenemase-producing Enterobacterales and Acinetobacter baumanniiPatricia García, Paula Guijarro-Sánchez, Cristina Lasarte-Monterrubio, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2024
Mutant prevention concentrations, <i>in vitro</i> resistance evolution dynamics, and mechanisms of resistance to imipenem and imipenem/relebactam in carbapenem-susceptible <i>Klebsiella pneumoniae</i> isolates showing ceftazidime/avibactam resistanceTania Blanco-Martín, Lucía González-Pinto, Pablo Aja-Macaya, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2026
Disarming carbapenemase-producing <i>Acinetobacter baumannii</i>: high potency of the novel therapeutic combination of meropenem and the innovative diazabicyclooctane β-lactamase inhibitor pilabactam (formerly ANT3310)Salud Rodríguez-Pallares, Michelle Outeda-García, Emilio Lence, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Vaccines|June 27, 2025
Engineering and Evaluation of a Live-Attenuated Vaccine Candidate with Enhanced Type 1 Fimbriae Expression to Optimize Protection Against <i>Salmonella</i> TyphimuriumPatricia García, Arianna Rodríguez-Coello, Andrea García-Pose, et al.
Journal of Physiology and Biochemistry|June 19, 2023
Study of hydrogen sulfide biosynthesis in synovial tissue from diabetes-associated osteoarthritis and its influence on macrophage phenotype and abundanceNatalia Lendoiro-Cino, Arianna Rodríguez-Coello, Anna Saborido, et al.
International Journal of Biological Macromolecules|September 18, 2023
Anti-inflammatory potential of ulvanNoelia Flórez-Fernández, Arianna Rodríguez-Coello, Thomas Latire, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2025
The novel polymyxin analogue SPR206 exhibits higher activity than colistin against both colistin-susceptible and colistin-resistant strains of <i>Acinetobacter baumannii</i>Michelle Outeda-García, Andrea Garcia-Pose, Paula Guijarro-Sánchez, et al.
New Microbes and New Infections|February 6, 2026
<i>Enterococcus thailandicus</i>: Genomic evidence of a potential new player in enterococcal virulence and antimicrobial resistanceJuan C Vázquez-Ucha, Ana C Almeida-Santos, David Velasco, et al.
Antimicrobial Agents and Chemotherapy|December 22, 2025
Antibacterial activity of enmetazobactam against <i>Acinetobacter</i> spp.: a molecular dissection of mechanism of action and resistance determinantsGabriela-Alejandra Báez-Barroso, Arianna Rodríguez-Coello, Juan Carlos Vázquez-Ucha, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 3, 2024
Activity and resistance mechanisms of the third generation tetracyclines tigecycline, eravacycline and omadacycline against nationwide Spanish collections of carbapenemase-producing Enterobacterales and Acinetobacter baumanniiPatricia García, Paula Guijarro-Sánchez, Cristina Lasarte-Monterrubio, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2024
Mutant prevention concentrations, <i>in vitro</i> resistance evolution dynamics, and mechanisms of resistance to imipenem and imipenem/relebactam in carbapenem-susceptible <i>Klebsiella pneumoniae</i> isolates showing ceftazidime/avibactam resistanceTania Blanco-Martín, Lucía González-Pinto, Pablo Aja-Macaya, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2026
Disarming carbapenemase-producing <i>Acinetobacter baumannii</i>: high potency of the novel therapeutic combination of meropenem and the innovative diazabicyclooctane β-lactamase inhibitor pilabactam (formerly ANT3310)Salud Rodríguez-Pallares, Michelle Outeda-García, Emilio Lence, et al.
Pageof 1